The human T-lymphotropic virus type 1 (HTLV-1) retrovirus infects 10–20 million people
globally, with endemic regions in southwestern Japan, the Caribbean basin, Africa, and …

Purpose of Review Human T-cell lymphotropic virus type 1 (HTLV-1)–associated
myelopathy (HAM) is a well-recognized neurologic complication of HTLV-1. Beyond HAM …

Some carriers of human T-cell leukaemia virus type 1 (HTLV-1), a retrovirus that primarily
infects CD4+ T cells and causes lifelong infection, develop HTLV-1-associated …

Objective Infectious myelopathy of any stage and etiology carries the potential for significant
morbidity and mortality. This article details the clinical presentation, risk factors, and key …

Background Human T-cell leukemia virus type 1 (HTLV-1) causes HTLV-1-associated
myelopathy (HAM), adult T-cell leukemia/lymphoma (ATL), HTLV-1-associated uveitis, and …

(CTL) and natural killer (NK) cells, suggesting the virus has developed effective mechanisms
to counteract host immune surveillance. We recently showed that in vitro treatment of HTLV …

ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …

Simple Summary Our findings provide observational evidence supporting oral
corticosteroids therapy as maintenance therapy for HTLV-1-associated myelopathy (HAM) …

Background HTLV-1 infection is a neglected disease. Over 10 million people are infected
worldwide, with hot spots of high endemicity across all continents. Roughly 5% of HTLV-1 …

Among the human T-lymphotropic virus (HTLV) types, HTLV-1 is the most prevalent, and it
has been linked to a spectrum of diseases, including HAM/TSP, ATLL, and hyperinfection …